{"id":"https://openalex.org/W4411287504","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p4-03-25","title":"Abstract P4-03-25: Actionable gene alterations affecting the PI3K/AKT and MAPK signaling pathways in breast cancer","display_name":"Abstract P4-03-25: Actionable gene alterations affecting the PI3K/AKT and MAPK signaling pathways in breast cancer","publication_year":2025,"publication_date":"2025-06-13","ids":{"openalex":"https://openalex.org/W4411287504","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p4-03-25"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.sabcs24-p4-03-25","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p4-03-25","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-p4-03-25","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110283375","display_name":"Gargi Dan Basu","orcid":"https://orcid.org/0000-0003-0352-5972","observed_orcids":["https://orcid.org/0000-0003-0352-5972"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gargi D. Basu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Karen White","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen White","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002784919","display_name":"Cynthia A. Flannery","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cynthia A. Flannery","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030479508","display_name":"Paige Innis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paige E. Innis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093725532","display_name":"Satish Seerapu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Satish Seerapu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063659002","display_name":"Jean\u2013Paul De La O","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Paul De La O","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5071432873","display_name":"Joyce O\u2019Shaughnessy","orcid":"https://orcid.org/0000-0002-2955-5523","observed_orcids":["https://orcid.org/0000-0002-2955-5523","https://orcid.org/0000-0001-6764-2807"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joyce O\u2019Shaughnessy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"12_Supplement","first_page":"P4","last_page":"03"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.396699994802475,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.396699994802475,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.3009999990463257,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.15440000593662262,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.8790000081062317},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.9980000257492065},{"id":"https://openalex.org/keywords/actionable-genomic-alterations","display_name":"actionable genomic alterations","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pik3ca","display_name":"PIK3CA","score":0.8849999904632568},{"id":"https://openalex.org/keywords/akt1","display_name":"AKT1","score":0.953000009059906},{"id":"https://openalex.org/keywords/pten","display_name":"PTEN","score":0.9990000128746033},{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.8650000095367432},{"id":"https://openalex.org/keywords/hr-her2-breast-cancer","display_name":"hormone receptor-positive HER2-negative breast cancer","score":0.7760000228881836},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9909999966621399},{"id":"https://openalex.org/keywords/tumor-subtypes","display_name":"tumor subtypes","score":0.44699999690055847},{"id":"https://openalex.org/keywords/targeted-therapy-eligibility","display_name":"targeted therapy eligibility","score":0.7210000157356262},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.6069999933242798}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.698026180267334},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6644592881202698},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.6225850582122803},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.588822603225708},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5680440068244934},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.5396928787231445},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5387372374534607},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.47909191250801086},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4555351734161377},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.45133501291275024},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4066222012042999},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3555423617362976},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2852140963077545}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.sabcs24-p4-03-25","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p4-03-25","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-p4-03-25","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3013910419","https://openalex.org/W2282174647","https://openalex.org/W2399931500","https://openalex.org/W3170823416","https://openalex.org/W2805612270","https://openalex.org/W4411286846","https://openalex.org/W2171931013","https://openalex.org/W3081940595","https://openalex.org/W2407004325","https://openalex.org/W2057232182"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"The":[2,44,67,177,259],"MAPK":[3,101,155,289,363,457],"and":[4,54,97,196,216,225,281,292,300,322,373,415,456],"PI3K/AKT":[5,95,146,180,211,361,455],"signaling":[6,62,458],"pathways":[7,63,459],"are":[8,17],"known":[9],"drivers":[10],"of":[11,46,56,72,132,169,179,279,283,303,327,349,394,400,413,466],"breast":[12,461],"cancer":[13,116,462],"(BC)":[14],"tumorigenesis.":[15],"They":[16],"increasingly":[18],"important":[19],"as":[20,26,107,421],"targets":[21,425],"for":[22,28,36,120,125,263,426],"therapeutic":[23],"intervention":[24],"such":[25],"capivasertib-fulvestrant":[27],"HR+HER2-":[29,192,206,366],"BC":[30,185,193,207,305,350],"with":[31,39,86,109,118,231,341],"PIK3CA/AKT1/PTEN":[32],"alterations,":[33],"or":[34,123,311,333,362],"dabrafenib\u2013trametinib":[35],"solid":[37],"tumors":[38],"the":[40,52,78,94,100,170,204,288,360,398,411,454,467],"BRAF":[41,312],"V600E":[42],"mutation.":[43],"goal":[45],"this":[47],"study":[48,68],"was":[49,269],"to":[50,309,396],"determine":[51],"frequency":[53,178],"co-occurrence":[55],"actionable":[57,355,368],"gene":[58,148,157,241,451],"alterations":[59,104,149,158,173,182,209,232,244,274,294,357,369,417,452],"affecting":[60,358,453],"these":[61,234,422],"in":[64,81,93,99,114,152,161,174,191,199,210,220,233,249,277,297,318,330,337,370,460],"BC.":[65,87],"Methods:":[66],"retrospectively":[69],"reviewed":[70],"results":[71],"tumor-normal,":[73],"whole-exome,":[74],"whole-transcriptome":[75],"testing":[76,387],"using":[77],"OncoExTra":[79],"assay":[80],"tumor":[82,134,351],"samples":[83,135,167,230,251,339,352],"from":[84,406],"patients":[85,401],"Thirty-one":[88],"genes":[89,213,235,395],"were":[90,105,144,150,159,218,245,275,295,316,335,375],"considered,":[91],"13":[92],"pathway":[96,147,156,181,212],"18":[98],"pathway.":[102],"Actionable":[103,450],"defined":[106],"those":[108],"associated":[110],"FDA-approved":[111],"targeted":[112,407],"therapies":[113],"any":[115],"type,":[117],"evidence":[119],"matched":[121],"therapies,":[122],"required":[124],"clinical":[126],"trial":[127],"eligibility.":[128],"Results:":[129],"A":[130],"total":[131],"2387":[133],"(66.1%":[136],"HR+HER2-,":[137],"15.0%":[138],"HER2+,":[139],"14.7%":[140],"TNBC,":[141],"4.2%":[142],"unspecified)":[143],"included.":[145],"present":[151,160,276,296,377],"48.2%":[153],"(1150/2387);":[154],"15.4%":[162],"(367/2387).":[163],"Of":[164],"these,":[165],"222":[166],"(9.3%":[168],"cohort)":[171],"had":[172,238,353],"both":[175],"pathways.":[176,364],"varied":[183],"by":[184],"subtype":[186],"(p<.0001),":[187],"occurring":[188],"most":[189],"often":[190,198],"(884/1577;":[194],"56.1%)":[195],"least":[197],"TNBC":[200],"(97/352;":[201],"27.6%).":[202],"Among":[203],"1577":[205],"samples,":[208,306],"PIK3CA,":[214,371],"AKT1,":[215,372],"PTEN":[217,264,374],"found":[219,317,336],"718":[221],"(45.5%),":[222],"84":[223],"(5.3%),":[224],"128":[226],"(8.1%),":[227],"respectively.":[228],"Most":[229],"(814/872;":[236],"93.3%)":[237],"only":[239,319],"one":[240,325],"involved.":[242],"PIK3CA":[243],"significantly":[246],"more":[247],"common":[248],"local/regional":[250,280],"vs":[252,256,266],"metastatic":[253,284],"sites":[254,285],"(43.4%":[255],"34.9%;":[257],"p=.0089).":[258],"converse":[260],"appeared":[261],"true":[262],"(4.6%":[265],"5%)":[267],"but":[268],"not":[270],"significant":[271],"(p=.0758).":[272],"AKT":[273],"4.6%":[278],"4.7%":[282],"(p=.9671).":[286],"In":[287,365,409],"pathway,":[290],"MAP3K1":[291,414],"MAP2K4":[293,416],"196":[298],"(8.2%)":[299],"63":[301],"(2.6%)":[302],"all":[304],"respectively,":[307],"compared":[308],"KRAS":[310],"activating":[313],"mutations,":[314],"which":[315],"37":[320],"(1.6%)":[321],"included":[323],"just":[324],"instance":[326],"V600E.":[328],"Alterations":[329],"TSC1,":[331],"TSC2,":[332],"NF1":[334],"75":[338],"(3.1%)":[340],"no":[342],"co-occurring":[343],"alterations.":[344],"Conclusions:":[345],"More":[346],"than":[347,380],"half":[348],"potentially":[354],"genomic":[356],"either":[359],"BC,":[367],"generally":[376],"independently":[378],"rather":[379],"co-occurring.":[381],"These":[382],"findings":[383],"support":[384],"a":[385,391],"comprehensive":[386],"approach":[388],"that":[389],"interrogates":[390],"large":[392],"number":[393,399],"maximize":[397],"identified":[402],"who":[403],"might":[404],"benefit":[405],"therapies.":[408],"addition,":[410],"presence":[412],"warrants":[418],"further":[419],"investigation,":[420],"may":[423],"represent":[424],"MEK":[427],"inhibitors.":[428],"Citation":[429],"Format:":[430],"Gargi":[431],"D.":[432],"Basu,":[433],"Karen":[434],"White,":[435],"Cynthia":[436],"A.":[437],"Flannery,":[438],"Paige":[439],"E.":[440],"Innis,":[441],"Satish":[442],"Seerapu,":[443],"Jean-Paul":[444],"De":[445],"La":[446],"O,":[447],"Joyce":[448],"O\u2019Shaughnessy.":[449],"[abstract].":[463],"In:":[464],"Proceedings":[465],"San":[468,477],"Antonio":[469],"Breast":[470],"Cancer":[471,484],"Symposium":[472],"2024;":[473],"2024":[474],"Dec":[475],"10-13;":[476],"Antonio,":[478],"TX.":[479],"Philadelphia":[480],"(PA):":[481],"AACR;":[482],"Clin":[483],"Res":[485],"2025;31(12":[486],"Suppl):Abstract":[487],"nr":[488],"P4-03-25.":[489]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}